-
Kim-1 as a Biomarker in RCC - 5 day(s) ago
Dear Colleagues, I wanted to share a collection on the promise of Kidney Injury Molecule-1 (KIM-1), a potential biomarker that is currently gaining attention in…
Cancer Biology With Katy Beckermann, MD, PhD
Oncology / HematologyDr. Katy Beckermann is a dedicated GU medical oncologist and clinical researcher. She is driven to provide exceptional care to patients facing the daunting diagnosis of cancer. Her passion lies in exploring the 'why' questions to propel our understanding forward and enhance treatment options through clinical trials.
-
Considerations in IO Refractory in RCC - 16 day(s) ago
Dear readers, This collection is meant to highlight our current understanding and needs for patients with RCC refractory to checkpoint inhibitors. The CONTACT-03 trial demonstrated…